- The understated importance of high-quality supportive care
- Medications to avoid in ICU
- Anemia & transfusion targets
- Glycemic control
- Nutrition for the intubated patient
- Pain, agitation, and delirium
- Volume status & diuresis
- Electrolyte management
- Troponin elevation & heparin drips
- Approach to fever in the ICU
- Questions & discussion
High-quality supportive care
High-quality supportive care consists of basic, daily management needed for any critically ill patient to prevent or surmount common problems. This isn't particularly flashy or exciting. However, it's essential for every patient passing through the intensive care unit. Minor interventions, when leveraged across thousands of patients, can have a substantial impact.
This chapter provides an overview of issues that commonly arise in the daily practice of critical care. The goal is to rapidly provide a basic foundation of knowledge, especially for folks who don't work full-time in the ICU (e.g., residents rotating through the unit). Links are provided to full chapters on these topics, to provide additional detail as needed.
Medications to avoid in ICU
benzodiazepines, diphenhydramine, zolpidem
- These drugs are popular for treatment of insomnia or agitation. However, they promote delirium and should be avoided.
- These medications will temporarily calm agitated patients, thereby appearing to work. However, they ultimately make patients worse by exacerbating their underlying delirium.
- In nearly all cases, better options exist:
- For insomnia: melatonin, quetiapine, clonidine, perhaps trazodone.
- For acute agitation: haloperidol, olanzapine.
- For sedation: dexmedetomidine, propofol, possibly quetiapine.
- Benzodiazepines should generally be restricted to the following situations:
- Status epilepticus
- Ketamine re-emergence, procedural sedation
- Patients who are chronically on benzodiazepines as a home medication
- Palliative sedation
- Occasional cases of alcohol withdrawal (although phenobarbital is usually preferable here).📖
- The kidney is usually the first organ to be damaged by hypoperfusion. Kidney injury correlates strongly with increased mortality. The following medications should therefore be avoided whenever possible.
- NSAIDs should be avoided as a rule in the ICU (due to both nephrotoxicity and risk of GI bleeding). Treatment of pain in critically ill patients is explored further below.📖 This does not involve NSAIDs.(11979336)
- ACE-inhibitors & angiotensin-receptor blockers (ARBs)
- ACEi/ARB generally shouldn't be initiated for control of blood pressure, except in select situations (e.g. chronic anuric renal failure, SCAPE 📖, or type-I myocardial infarction 📖). For patients on ACEi/ARB solely for hypertension, consider holding these.
- ACEi/ARB should often be continued for patients with heart failure and reduced ejection fraction who are already on these medications chronically.
- For patients admitted for heart failure, instead of initiating an ACEi/ARB consider using hydralazine plus isosorbide dinitrate (similar physiologic effects with less nephrotoxicity).📖
- Vancomycin is grossly over-utilized. Vancomycin has no role for community-acquired abdominal sepsis or urinary sepsis. Most patients with non-purulent cellulitis may be treated simply with cefazolin. Linezolid may be preferable to vancomycin for MRSA pneumonia, especially among patients with tenuous renal function.
My extensive tramadol treatment decision algorithm: pic.twitter.com/PPaKg5IBsQ
— Kyle DeWitt (@EmergPharm) September 15, 2018
- Tramadol is a weak opioid with a host of side effects (seizures, delirium, serotonin syndrome, hypoglycemia).
- The efficacy of tramadol is erratic, depending on genetic variation and interacting drugs.(23509136)
- Tramadol is sometimes promoted as a “non-opioid” but this isn't true. Tramadol is an opioid, it's just a really poor one.
- The only reason to consider using tramadol is if the patient is chronically on tramadol as a home medication.🌊 🌊
- Over-utilization of fluoroquinolone has caused marked increases in antibiotic resistance.(21996380, 21144988) Meanwhile, problems with C. difficile, MRSA, neuropathy, delirium, and tendinopathy have grown more apparent. 🌊(17884829, 16477553, 16206099, 22921930, 25700059, 26330729, 25423877, 11793615) The FDA consequently issued a series of black box warnings on fluoroquinolones.🌊
- Fluoroquinolones are almost never the best choice for critically ill patients. Previously, fluoroquinolones were frequently used for treatment of pneumonia in patients with penicillin allergy, but newer evidence has shown that 3rd-4th generation cephalosporins are generally fine for such patients. 📖 (21742459)
- There is no convincing evidence that double-coverage for gram-negative pathogens is beneficial (even for ventilator-associated pneumonia or pseudomonal infections – situations where double-coverage would seem most beneficial). 🌊 (18091545, 9377880, 24395715, 22763634, 24139926, 23410791)
- A single broad-spectrum beta-lactam is generally adequate. Addition of an aminoglycoside provides little additional coverage, but does increase nephrotoxicity.
all patients should get DVT prophylaxis unless they have one of the following contraindications:
- (1) Hemorrhage.
- (2) Thrombocytopenia (platelet count <30,000 or <50,000 and falling)(22929300)
- (3) Planned procedure:
- DVT prophylaxis isn't a significant problem for most ICU procedures, with the exception of lumbar puncture.
- Interventional radiology may prefer to hold DVT prophylaxis; when in doubt this should be clarified with them in advance.
- (Note: Patients with cirrhosis and elevated INR are generally not coagulopathic and generally do require DVT prophylaxis.)(23506859)
DVT prophylaxis if GFR > 30 ml/min
- Enoxaparin (low molecular-weight heparin) is the preferred agent for the following reasons:
- Fewer injections than s.q. heparin, limiting patient discomfort.
- Reduced risk of HIT compared to unfractionated heparin.
- Enoxaparin may be more effective.(23782973)
- Usual dose is 40 mg enoxaparin sq daily.
- Weight-based dose adjustments:
- Monitoring anti-factor Xa levels:
- Consider this for patients with unusual weight, pregnancy, or borderline renal function.
- Check an anti-factor Xa level four hours after the third dose (target level ~0.3-0.5 IU/ml).📖
DVT prophylaxis if GFR <30 ml/min
- Unfractionated heparin is used here, because it's not cleared by the kidneys.
- Usual dose: 5,000 IU s.q. TID.
- Weight-based dose adjustments:
- For patients weighing <50 kg, reduce the dose to 5,000 sq BID.
- For patients weighing >120 kg, consider scaling the dose up roughly proportional to the patient's weight.
- For intubated/coagulopathic patients on aspirin for no good reason (e.g. “primary prevention”), please discontinue this.
- Always avoid NSAIDs in ICU patients.(11979336)
- Enteral nutrition should be provided whenever possible.📖
who needs pharmacologic GI prophylaxis?
- Nobody really knows. The rate of stress ulceration has fallen with modern critical care practices (e.g. early enteral nutrition).(25029573) Thus, the benefit of pharmacologic GI prophylaxis is probably restricted to a smaller group of patients with more risk factors.
- Our usual practice is currently to provide stress ulceration prophylaxis to the following groups of patients:
- (1) Intubated patients.
- (2) Non-intubated patients with numerous risk factors for stress ulceration (e.g. coagulopathy, profound uncontrolled shock, recent history of prior GI bleed, steroid therapy at a dose equivalent to >60 mg prednisone daily).(8284001)
- (3) Consider GI prophylaxis for sick COVID patients on dexamethasone.
what is the preferred agent for GI prophylaxis?
- The pendulum keeps swinging back and forth between proton pump inhibitors versus H2-receptor blockers. Either one is fine.
- Currently pantoprazole 40 mg PO/IV daily may be preferable for the following reasons:
- (1) Greater efficacy compared to H2-receptor blockers.(23318494, 15996033)
- (2) Possibly lower risk of delirium compared to H2-receptor blockers.(22949902, 11573854)
- (3) Prior fears about increased risk of C. difficile or pneumonia have been debunked by new evidence from the SUP-ICU trial. 🌊 (30354950)
- Oral pantoprazole is cheaper than IV, so this is preferred if the patient is able to take enteral medications.
Anemia & transfusion targets
the ICU hemoglobin drift
- Most patients in ICU will experience a gradual decrease in hemoglobin, which is caused by several factors:(12576944)
- (1) Suppression of hematopoiesis by critical illness.
- (2) Phlebotomy from serial lab measurements.
- (3) Subclinical loss from the GI tract (minor stress ulceration).
approach to falling hemoglobin
- Acutely falling hemoglobin can be caused only by bleeding or hemolysis (not reduced blood synthesis, which can cause only chronic anemia). Therefore, the investigation of acute anemia should focus on sources of blood loss and hemolysis. Checking iron labs, B12, and reticulocyte count is generally a waste of resources.
- Investigation may include: Repeat CBC, LDH to exclude hemolysis, ultrasonography to look for hemoperitoneum/hemothorax, CT angiography.
- Conservative blood transfusion if needed (as below).
- Avoid lab draws as able.
- Treat any overt source of bleeding.
- For patients with persistently dropping hemoglobin without any explanation, consider empiric proton pump inhibitor for therapy of probable stress ulceration (e.g., 40 mg pantoprazole PO BID).
conservative transfusion strategy 📖
- Hemodynamically stable patients with anemia should be treated with a conservative transfusion strategy. Blood transfusion causes numerous complications (e.g., volume overload, transfusion-related acute lung injury, transfusion reactions). Conservative transfusion practices improve outcomes – in some cases even mortality.(23281973)
- Blood transfusion should be given if the hemoglobin falls below a transfusion target:(28284299)
- For post-CABG patients and patients with active myocardial ischemia: transfuse if hemoglobin <8 mg/dL.
- For everyone else (the vast majority of patients): transfuse if hemoglobin <7 mg/dL.
- Blood should generally be transfused one unit at a time (unless the patient is actively bleeding or the hemoglobin is definitely very low).(19773646) Why? Two reasons:
- Hemoglobin bounces around due to random variation in the laboratory. Over-reacting to a low hemoglobin with two units of blood will often over-correct the anemia.
- Blood transfusion tends to cause pulmonary edema (more so than crystalloid). Two units of blood is a significant volume challenge for an ICU patient who will often have euvolemic or hypervolemic anemia.
better sweet than sour
- Hypoglycemia may cause permanent brain damage and cardiopulmonary arrest. This is especially dangerous among intubated and sedated patients, who can develop severe hypoglycemia without any signs or symptoms (altered mental status will be masked by sedation).
- Hyperglycemia will not kill the patient. It's controversial to what extent hyperglycemia may be dangerous. Hyperglycemia undoubtedly correlates with poor outcomes, but it's unclear to what extent (if any) it causes harm.
- When in doubt, err on the side of avoiding hypoglycemia. Use insulin cautiously, paying attention to changes in steroid dosing and caloric intake (e.g., new NPO orders).
- ICU patients should receive occasional glucose checks to avoid occult hypoglycemia.
glycemic targets ??
- It's unknown when we should treat hyperglycemia. Enormous energy is spent achieving various glycemic targets, but these targets are arbitrary. No RCT has shown that treatment of hyperglycemia in critically ill patients improves outcomes (except for the Leuven 2001 study, which was subsequently debunked by VICEP and NICE-SUGAR).(11794168, 18184958, 19318384)
- The most recent American College of Physicians guideline recommends a glucose target of 140-200 mg/dL (7.8-11.1 mM).(23709472) Other authors have suggested 140-220 mg/dL (7.8-12.2 mM).(23470218)
- Diabetic patients with chronic hyperglycemia may benefit from a greater degree of permissive hyperglycemia, because that's what they are used to. Among patients with hemoglobin A1C >7%, mild hyperglycemia may actually correlate with better outcomes. One pilot study demonstrated the safety of targeting a glucose level of 180-250 mg/dL (10-14 mM) among such patients.(27315191)
Nutrition for the intubated patient
most intubated patients should be fed 📖
- Benefits of enteral nutrition:
- Maintains gut integrity, preventing bacterial translocation into bloodstream.
- Prevents development of ileus.
- Reduces stress ulceration.
- Prevents malnutrition.
- Avoids the development of starvation ketoacidosis.
- Patients should be fed unless there is a legitimate contraindication to feeding:
- When in doubt, start feeds at a low level and advance as tolerated.
- Absence of bowel sounds isn't a contraindication to feeding. There is little evidentiary support for listening to bowel sounds at all, so this is generally a waste of time.(19966732)
route of feeding 📖
- Most intubated patients will initially have an orogastric (OG) tube placed. This can be used for feeding.
- A post-pyloric small-bore soft feeding tube may be subsequently placed, for one of the following reasons.
- (1) Post-pyloric feeding can be useful for patients with gastroparesis or vomiting (since it bypasses the stomach).
- (2) A smaller-bore nasal feeding tube is more comfortable and can be left in place longer (e.g., after the patient has been extubated). This may be useful in patients with hepatic encephalopathy or neurologic injury, in whom it is important to maintain gut access following extubation.
- The minor drawback of a small-bore tube is that it cannot be used to suction the stomach (e.g., to empty the stomach prior to extubation).
initial nutrition orders 📖
- Start with a standard 1 kCal/ml tube feed (e.g. Replete). Target a goal rate of somewhat below ~1 ml/hr/kg. For example, a 77 kg patient would receive ~60 ml/hour. In morbid obesity use the ideal body weight.
- In severe renal failure, use a 2 kCal/ml renal tube feed (e.g. Novasource Renal) at a rate of 0.5 cc/kg/hour.
- The nutrition team will adjust your orders, but the most important aspect is to provide some enteral nutrition. The precise number of calories doesn't seem to have a huge impact – the key thing is providing a reasonable amount of nutrition.(30346225)
gastric residual volume 📖
- Recent nutrition guidelines recommend against checking gastric residual volume.(26773077, 19861528, 23321763)
- Tube feeds shouldn't be held based on elevated gastric residual volumes. Feeding may be continued unless there are clinical signs of feeding intolerance (e.g. abdominal distension/discomfort, emesis).
Analgesia & pain management
The best approach to pain is a structured, multi-modal strategy which uses several medications at low doses. Using lower doses avoids toxicity from each medication, while the use of several medications provides synergistic efficacy. 📖
#1 acetaminophen 📖
- Useful agent, either as an adjunct or the sole therapy for minor pain.(20189753)
- Most patients can receive up to 4 grams/day. It's often useful to schedule this (e.g., 1 gram q6hr) to keep ahead of pain.
- Patients with alcoholism or chronic liver disease can receive up to 2 grams/day.(25477978) Acetaminophen is contraindicated in acute hepatic injury.
#2 PRN opioids 📖
- Often used as second line therapy, mostly due to convenience.
- IV fentanyl works rapidly, but has a relatively short half-life so it may require frequent re-dosing.
- IV hydromorphone may be more effective, given its longer half-life. Note that hydromorphone is much more potent than morphine, so relatively low doses should be given (e.g., 0.2-0.4 mg IV).
- Oral opioids may be preferable for more stable patients with moderate pain who are able to take oral medications.
#3 ketamine infusion +/- clonidine/dexmedetomidine
- Ketamine a mild-moderate amount of analgesia. 📖 Ketamine has been shown to reduce opioid requirements and decrease the incidence of nausea/vomiting.(12933413, 26025196, 28468568) Ketamine may also attenuate the development of opioid tolerance and opioid-induced hyperalgesia, thereby making co-administered opioids safer and more effective.(23269131, 14581110, 15983467, 16854557)
- Ketamine is extraordinarily safe. Although sometimes feared due to its classification as an “anesthetic” agent, ketamine is actually the safest medication listed here (unlike acetaminophen or opioids, it's nearly impossible to kill someone with ketamine).(25530168, 10499950)
- The dose for a ketamine infusion to treat pain typically 0.1-0.3 mg/kg/hr. At the higher end of this dose range, some patients may experience mild psychotropic side-effects which are often pleasurable (but can be scary). If psychomimetic side-effects occur, stop the infusion for 30-60 minutes and re-start at a lower dose (e.g., 0.1 mg/kg/hr). It's generally possible to find a sweet spot where pain relief is achieved without side-effects.
- Dexmedetomidine or clonidine synergize with ketamine to improve analgesia. 📖(23711600, 20648205, 19095506) Dexmedetomidine or clonidine also prevent psychomimetic side-effects of ketamine, thereby further enhancing the safety of ketamine.(29870458, 19783371, 9507131, 27656531, 10773503, 26919405) Unfortunately, these are contraindicated among patients with bradycardia, heart block, or hypotension.
#4 fentanyl infusion
- Fentanyl infusions should be avoided whenever possible, for many reasons. Over several days patients will rapidly become tolerant to opioid, which may subsequently cause withdrawal when fentanyl is discontinued.(22420584) Fentanyl accumulates in adipose tissue, causing the drug to linger after the infusion is stopped, leading to delayed awakening. 🌊 (26346209)
- A 25 mcg/hr fentanyl infusion is equivalent to 120 mg oxycodone per day. Unless the patient has some extraordinary source of pain, 25-50 mcg/hr of fentanyl should be sufficient. High-dose fentanyl infusions can actually exacerbate pain, a phenomenon known as opioid-induced hyperalgesia.(26095487)
- If a fentanyl infusion is used, attempts should be made on a regular basis to reduce the dose (at a minimum, every morning).
make sure you're targeting pain
- Analgesics shouldn't be used as nonspecific “calm down” medication for any agitated patient. Ideally, they should be targeted specifically at pain.
- For patients unable to communicate, a behavioral pain scale can help determine whether the patient is in pain.
Sedation of the intubated patient
Intubated patients will generally require a sedative infusion. Propofol or dexmedetomidine are front-line choices, without any solid evidence that one is superior to the other. In practice, propofol is generally used initially. Dexmedetomidine is often useful once the patient is within a few days of extubation.
- Easily & rapidly titrated.
- May cause hypotension, but this can be counteracted with an infusion of low-dose phenylephrine (e.g. ~0-80 mcg/min) or norepinephrine (e.g. ~0-8 mcg/min).
- Use of high doses for prolonged periods of time may cause hypertriglyceridemia and a risk of propofol infusion syndrome. Over extended periods of time, it's ideal to wean the dose down to <50 mcg/kg/min.
- The major advantage of dexmedetomidine is that it doesn't suppress respiration, making it safe to use in a non-intubated patient. Therefore, dexmedetomidine may be continued throughout the weaning process (unlike propofol, which must be shut off prior to extubation). This is an excellent option for patients who develop anxiety and tachypnea whenever sedation is lifted, making it difficult to extubate them.(26975647)
- Dexmedetomidine may cause hypotension due to bradycardia, but this can be counteracted with an infusion of low-dose epinephrine if the use of dexmedetomidine is critical.
- Boluses of dexmedetomidine should be avoided, as these can cause bradycardia in hemodynamic instability. Instead, the infusion can be started at a relatively high rate (e.g. 1-1.4 mcg/kg/min) without a bolus, and then down-titrated within 30-60 minutes.
- Dexmedetomidine can cause tolerance over ~4-5 days, with subsequent withdrawal when it is discontinued.(22477787) Avoid continuing dexmedetomidine infusions for longer periods of time. If tolerance occurs, dexmedetomidine may be transitioned to oral clonidine. 📖 (25809176)
sedating atypical antipsychotics
- Quetiapine has sedating effects and efficacy in anxiety disorders.(29110139) Quetiapine may be useful for its sedative properties, in order to allow a reduction in the dose of propofol or dexmedetomidine that is required. 📖 (19915454)
- Benzodiazepines are the sedative of last resort. They should be avoided whenever possible.📖
- Benzodiazepines may occasionally be needed for patients with profound hemodynamic instability, in whom propofol or dexmedetomidine are contraindicated.
Delirium is extremely common in the ICU (prevalence of ~50%). This makes it worthwhile to deploy preventative measures broadly.
general delirium prevention measures 📖
- Scheduled melatonin agonist before sleep may be beneficial (melatonin 3 mg or ramelteon 8 mg). 🌊 (24554232, 29595562, 20845391, 25969139)
- Ear plugs and eye shades at night, if tolerated.(26741578)
- Avoid unnecessary sleep interruption (e.g., frequent blood pressure cuff monitoring, neuro checks).
- Use of glasses & hearing aids during the day.
- Aggressive physical therapy and early mobilization.
insomnia treatment strategy
- Quetiapine 25-50 mg is often effective, but ideally should be given early in the night (to prevent somnolence the following day and day/night reversal). 📖
- Dexmedetomidine infusion is an excellent option for insomnia and nocturnal agitation.(29498534) The main limitations are logistic (this is an expensive intervention which cannot be used on the general ward).
- If dexmedetomidine is used for insomnia or nocturnal agitation, it should be discontinued or aggressively down-titrated the following morning. Reserving dexmedetomidine for nocturnal use may promote preservation of a normal circadian rhythm.
- Oral clonidine (0.2-0.3 mg QHS) may be considered as an alternative to dexmedetomidine for mild insomnia.
Volume status & diuresis
avoid volume overload
- Critically ill patients will generally tend to retain fluid and become volume overloaded. Without attention to volume status, this may lead to profound volume overload. Numerous studies correlate positive fluid balance with mortality.(26073560, 28130687)
- Follow your patient's volume status carefully. If the patient is consistently gaining fluid or becoming >4-5 liters net positive, this is a problem which requires management.
- Allowing patients to develop highly positive fluid balance (e.g., >4-6 liters positive) is a hallmark of poor-quality critical care.
- Avoid maintenance fluids. Most patients will receive plenty of fluid via medications, infusions, and enteral nutrition.(26768425) Maintenance fluid should be restricted unless there is a specific indication (e.g., rhabdomyolysis or diabetic ketoacidosis).
- Exception: For healthy patients with normally functioning kidneys and heart (e.g., young intoxicated patients), maintenance fluids are reasonable because such patients don't tend to retain fluid. However, you should still follow input/output to ensure that the patient isn't retaining fluid.
don't blindly chase low urine output or elevated lactate with fluid
- It is quite uncommon for patients in the ICU to be truly volume depleted:
- Most patients will be adequately fluid resuscitated in the emergency department.
- Patients will usually retain fluid, so they will generally tend to develop fluid overload.
- Fluid should be given only if, after careful examination (often with POCUS) and review of the clinical history, there is evidence of true volume depletion.
- Lactate elevation may occur for numerous reasons, most of which have little to do with volume status (e.g., albuterol or epinephrine administration). A rising lactate level calls for global reevaluation of the patient, not knee-jerk fluid administration. It's doubtful that cycling lactate is beneficial anyway, because it usually doesn't reflect tissue perfusion.🌊 🌊
- Don't check central venous pressure or use this to guide volume resuscitation (with the exception of patients with right ventricular dysfunction). Central venous pressure generally doesn't correlate with volume status or fluid responsiveness.(23774337, 18628220)
if you're going to give fluid, LR is generally superior to normal saline
- LR is generally the fluid of choice in the ICU with the following two exceptions:
- 1) Patients with elevated intracranial pressure (plasmalyte may be preferable).
- 2) Patients with metformin-induced lactic acidosis (optimal fluid in this situation is hotly debated, but the answer definitely isn't LR 📖).
- Don't be afraid to use LR in hyperkalemia, this is not a contraindication to the use of LR. 🌊 (15845718, 18569935, 22237237, 29121282)
- Normal saline causes a dilutional acidosis (pH =5) and may also impair renal perfusion.(23073953, 22580944) RCTs have demonstrated that NS may increase the risk of renal failure.(29485926, 29485925)
- The use of normal saline should be restricted to patients with metabolic alkalosis.🌊
balanced diuresis 📖
- It's not uncommon to encounter patients who are 5-10 liters positive, often due to over-resuscitation at an outside hospital. These patients will benefit from aggressive diuresis if tolerated.
- Use of furosemide alone tends to cause excretion of dilute urine, causing hypernatremia. This hypernatremia must then be treated by administration of free water, so the net result is ineffective diuresis.
- Addition of a thiazide diuretic (e.g. indapamide 5 mg PO daily) will enhance renal excretion of sodium, facilitating effective diuresis without the development of hypernatremia.(26948252) 📖
- If contraction alkalosis is developing and the patient remains hypervolemic, IV acetazolamide may be needed to prevent worsening alkalosis. For patients who are undergoing active diuresis, a reasonable dose is 500-1000 mg IV q12 hr.(26836730)
- Follow electrolytes, with aggressive repletion of potassium and magnesium as needed.
- Hypernatremia should never be tolerated, because this will cause the patient to be miserable (they will be profoundly thirsty yet unable to drink).
- Untreated hypernatremia is an under-recognized and under-treated cause of agitation among intubated patients. Too often it's treated with sedatives, rather than water.
- The vast majority of hypernatremia in the ICU is due to inadequate administration of free water. A diagnostic workup usually isn't needed (unless the patient has brain injury and there is concern for central diabetes insipidus).
- Hypernatremia should be treated by administration of free water (preferably via the gut, or otherwise in the form of intravenous D5W).
- Free water deficits are generally under-estimated. It's useful to calculate them.🧮
- Don't just arbitrarily give some random amount of water – calculate exactly how much water is required to achieve the desired drop in serum sodium.
- For patients with chronic hypernatremia (stable elevation >48hr), target reducing the sodium by 12 mM per day. Don't worry about overshooting this a bit unless your patient is <30-40 years old (the risk of cerebral edema seems to be very low in older patients).
- If the sodium is creeping upwards, be proactive in treatment of hypernatremia. If mild hypernatremia is ignored, it will generally get worse over time (hypernatremia usually represents a free water deficit, which cannot improve on its own).
- Don't treat hypernatremia with half-normal saline (this is an inefficient treatment of hypernatremia which will tend to cause sodium/volume overload).
- For patients with simultaneous volume overload plus hypernatremia, both processes should be treated simultaneously:
- Furosemide plus high-dose thiazide may be used to promote sodium excretion (natriuresis; discussed in the section above).
- Free water administration is provided to treat hypernatremia.
- Follow electrolytes, with aggressive repletion of potassium & magnesium. Follow input/output balance and target a negative fluid balance.
- Mild subacute or chronic hyponatremia is common in critical illness (e.g. sodium ranging 125-135 mEq/L). This doesn't require aggressive management or evaluation.
- Traditional treatment with kayexalate is ineffective and shouldn't be utilized. The most effective treatment for hyperkalemia is usually kaliuresis: stimulation of potassium excretion by the kidneys using a combination of diuretics and fluids. However, patients with end-stage renal disease on chronic dialysis will simply need to be dialyzed.
- Mild hyperkalemia: Furosemide alone may be fine.
- Severe hyperkalemia: A more aggressive diuretic regimen may be indicated, especially for patients with severe hyperkalemia who will require urgent dialysis if they don't respond. A maximally aggressive diuretic combination is the nephron bomb which consists of ~200 mg IV furosemide, 500-1000 mg IV chlorothiazide, and 500-1000 mg IV acetazolamide.
- The goal here is to bring the patient to a point of euvolemia and keep them there. Patients who produce copious amounts of urine in response to diuresis should have this fluid volume replaced.
- For patients with significant metabolic acidosis (serum bicarbonate <20 mEq/L), the preferred fluid is isotonic bicarbonate (D5W plus three 50-mEq ampules of bicarbonate to generate a 150 mEq/L solution of sodium bicarbonate).📖
- For patients without metabolic acidosis, the preferred fluid is lactated ringers, plasmalyte, or normosol.
- Normal saline is contraindicated in hyperkalemia, because it will worsen it.(15845718, 18569935, 22237237, 29121282)
- Fludrocortisone (0.2 mg PO) may be useful to promote potassium excretion, particularly among patients taking ACE-inhibitors or ARBs.
- Hypokalemia isn't as dangerous as commonly perceived (mild hypokalemia is generally well tolerated in the absence of digoxin use or hypomagnesemia).
- When possible, potassium should be repleted via the gut. Administration of enteral potassium is easier, cheaper, and safer than IV potassium. It's hard to kill someone with enteral potassium, whereas this isn't necessarily that difficult with IV potassium.
- Check the magnesium level and replete if necessary. Hypokalemia and hypomagnesemia often coexist. Hypomagnesemia will cause ongoing potassium wasting, so successful repletion of potassium may depend on fixing the magnesium as well.
- Be very cautious about treating hypokalemia in patients with severe renal failure:
- The target potassium might be around 3-3.5 mEq/L in this scenario (don't shoot for a stone-cold “normal” potassium level; the potassium level will rise over time).
- Check and replete the magnesium level (target >2 mg/dL), as this will protect against Torsade de pointes and increase the safety margin for mild hypokalemia.
- Discontinue PRN potassium orders.
- Common in critically ill patients.
- Should be treated with IV magnesium sulfate (oral magnesium causes diarrhea and is ineffective at improving serum magnesium levels).
- Patients with total body magnesium depletion (e.g., alcoholics) may require ongoing therapy to achieve eumagnesemia.
- Critically ill patients are very commonly hypocalcemic. This is an epiphenomenon of critical illness, which doesn't seem to actually cause harm (with certain exceptions, most notably massive transfusion).
- Treatment of mild hypocalcemia is generally ineffective and might actually be harmful.(26836894)
- Unless the calcium is very low (e.g. ionized calcium < 0.7 mM) and/or the patient seems to be demonstrating symptoms of hypocalcemia, it's generally best not to administer calcium.
- Overall, it's probably best not to check calcium levels, with the exception of admission labs or a specific reason to expect hypocalcemia (e.g., massive transfusion protocol).
MI & ischemia evaluation in the non-cardiac patient
This section describes the approach to troponin elevation in the “non-cardiac” patient – that is, a patient admitted to the ICU for a non-cardiac problem (e.g. septic shock).
do not check troponin routinely in all ICU patients
- About ~40% of ICU patients will have troponin elevation, but the vast majority of these patients are not having a plaque-rupture (type-I) MI.(28979516)
- EKGs should be routinely obtained on all ICU patients (if nothing else, this serves as a baseline for comparison throughout the patient's hospital stay).
- Troponin should be checked only if there is a genuine clinical suspicion for myocardial infarction based on the EKG and clinical presentation.
sorting out three categories of troponin elevation 📖
- Unfortunately, troponin levels are often obtained when they aren't actually indicated. When this occurs, we need to sort out what is causing the troponin elevation.
- A key concept here is the universal definition of a myocardial infarction, which requires:(30571511)
- 1) Dynamic rise/fall in troponin levels
- 2) At least one of the following: clinical history suggests MI (e.g., anginal chest pain), new ischemic EKG changes, or new wall motion abnormality on echocardiography.
- Using this definition, troponin elevation can be sorted into three categories:
- Non-MI troponin elevation (myocardial injury)
- These patients have troponin elevation without other features of MI (they don't meet the definition of MI above).
- This is extremely common among critically ill patients and requires no treatment.
- There is no therapeutic benefit to ongoing cycling of the troponin in this situation.
- Type-I MI (plaque rupture MI)
- These patients have classic MI due to plaque rupture and acute coronary thrombosis. Most patients with type-I MI will initially present to the hospital with cardiac-related signs or symptoms. Type-I MI can arise as a complication of critical illness, but this is rare.
- Type-I MI should be treated with the typical treatment regimen generally associated with MI if possible (e.g., aspirin, P2Y12 inhibitor, possibly cardiac catheterization). However, the ability to provide such treatments is often limited by bleeding, hypotension, and acute kidney injury.
- Type-II MI (demand ischemia)
- These patients have MI due to a fixed coronary lesion plus physiologic stress (figure above).
- Sorting out type-I vs. type-II MI can be tricky (the table below may help guide this). When in doubt, urgent echocardiography can be helpful.
- The treatment for type-II MI focuses on treatment of the underlying disease (e.g. anemia, sepsis, hypoxemia). Aspirin is reasonable, but otherwise these patients don't require specific treatment directed towards plaque stabilization.
use a heparin infusion only if truly indicated
- Troponin elevations are scary and we may feel compelled to do something. However, initiating a heparin infusion is rarely wise here. Heparin is indicated only if both of the following two conditions are met:🌊
- (1) The patient has a type-I (plaque-rupture) MI. This can occur in patients who present with non-cardiac diagnoses, but it's uncommon.
- (2) There is a plan to take the patient for urgent/emergent cardiac catheterization.
- More on the management of Type-I MI here.📖
Noninvasive respiratory support (HFNC & BiPAP)
when to choose BiPAP 📖
- Contraindications to BiPAP:
- Secretions (BiPAP generally impairs expectoration).
- Aspiration risk, altered mental status.
- Diseases that are exquisitely BiPAP-responsive:
- COPD, Asthma.
- Cardiogenic pulmonary edema.
- Obesity hypoventilation syndrome.
- Sedation to facilitate BiPAP tolerance
- Generally worth trying for patients with COPD/asthma or heart failure who have difficulty tolerating BiPAP.
- Dexmedetomidine is ideal, given its titratability and lack of respiratory suppression.
- Avoid benzodiazepines (they occasionally work, but often cause patients to be agitated/confused thereby worsening the situation).
- Some options may include: haloperidol, carefully titrated fentanyl for patients with severe air hunger.
how to titrate BiPAP
- Simply sticking the patient on BiPAP isn't enough – you need to titrate settings to obtain optimal benefit. The FiO2 may simply be titrated against the patient's oxygen saturation. The tricky part is adjusting the inspiratory and expiratory pressures.
- Cardiogenic pulmonary edema
- Key here is the expiratory pressure (this increases the mean airway pressure and thereby decreases preload & afterload).
- Ramp up expiratory pressure until the patient improves (e.g. 10/5 ==> 15/10 ==> 18/15), It’s also fine to simply use continuous positive airway pressure (CPAP). In that case, escalate CPAP pressure from 5 ==> 10 ==> 15 cm.
- Everything else
- The key here is driving pressure (inspiratory pressure minus expiratory pressure), which supports the work of breathing.
- Ramp up the driving pressure until the patient improves (e.g. 10/5 ==> 15/5 ==> 18/5).
when to choose HFNC
- Any patient with significant respiratory distress who doesn't have specific indications for BiPAP (above).
- The most common indication is pneumonia.(25981908)
- Can be used in situations where BiPAP is preferred, yet patients cannot tolerate BiPAP (e.g. COPD, pulmonary edema).
- HFNC is the safest mode of noninvasive support, so when in doubt this is a reasonable choice.
how to titrate HFNC
- FiO2 is titrated against the patient's oxygen saturation.
- Initially when the patient is in distress, flow rate should be increased as high as tolerated, usually 50-60 liters/minute (this provides the maximal amount of ventilatory and PEEP support).
- After the patient is improving, flow rate can be weaned down. If there are signs of tachypnea or dyspnea, this may indicate that the patient isn't ready for weaning.
post-extubation prophylactic HFNC 📖
- Extubation directly to HFNC has been shown to reduce the risk of reintubation, even in patients who are low risk for reintubation.(25003980, 26975498)
- With the exception of patients intubated very briefly for procedures, post-extubation HFNC is worthwhile.
- For maximal benefit, HFNC should be increased to the highest flow rate tolerated (ideally 50-60 liters/min) and continued for ~24 hours.
- The mechanism of action seems to be that HFNC reduces the work of breathing, thereby preventing patients from developing respiratory fatigue. In order for this to be effective, it should be started promptly following extubation (not in a delayed fashion after patients develop severe dyspnea).
Respiratory monitoring (including ABG, VBG and etCO2)
- The best way to monitor oxygenation is pulse oximetry. Pulse oximetry is preferred over ABG monitoring because pulse oximetry directly measures oxygen saturation (whereas portable ABG meters calculate oxygen saturation).🌊
- Oxygen saturation (not pO2) is the most important variable because this most directly measures oxygen delivery to the body's tissues.
- Shooting for a target oxygen saturation of ~90-96% is generally optimal, for a few reasons:(30355567)
- Excessive amounts of oxygen (hyperoxia) can be dangerous, especially following cardiac arrest.
- If an unnecessarily high amount of oxygen is used, this will mask early clinical deterioration (the patient will need to worsen a lot before they desaturate).
- For patients with chronic hypercapnic respiratory failure (e.g. COPD), target a saturation of 88-92%.(30355567) Lower pO2 in the lungs may improve ventilation/perfusion matching, thereby improving removal of CO2.
ventilation: what are we targeting ??
- Honestly, nobody really knows. This implies that we shouldn't be dogmatic or obsessive about adjusting/monitoring ventilation.
- Upper safe limit for pCO2 ??
- Hypercapnia is generally tolerated extremely well (for example, there are COPD patients living in the community right now with a pCO2 >80 mm).
- Permissive hypercapnia refers to the concept that allowing some hypercapnia is fine. Among patients with COPD/asthma or ARDS, some hypercapnia is preferred because this facilitates lung-protective mechanical ventilation.
- The lower limit of pH below which hypercapnia becomes harmful is unknown. pH >7.2 is definitely fine, and pH >7.1 is probably fine as long as hemodynamically tolerated. There doesn't appear to be any specific pH cutoff below which the patient will turn into a pumpkin.
- Lower safe limit of pCO2 ??
- Respiratory alkalosis (hypocapnia) may be less well tolerated than hypercapnia. There is a potential risk of seizure at pH >7.5
- So: for most patients we're targeting a pH of roughly 7.2-7.5
- The target range of pCO2 will depend on the bicarbonate (using the Henderson-Hasselbach equation).🧮
- For example, for a patient with bicarbonate of 24, a safe pCO2 would be 30-65 mm.
- For patients with elevated intracranial pressure, pregnancy, or severe pulmonary hypertension it might be safer to target normocarbia (pCO2 35-45 mm). More attention will be needed to blood gas parameters in these patients.
when to check ABG/VBG?
- Overall these are checked far too often, with the vast majority of results having minimal/no effect on clinical management.🌊
- ABG/VBG values generally provide no diagnostic information regarding why a patient is in respiratory failure (with the exception of hyperventilation due to anxiety).(21663600) Checking a blood gas for a patient in respiratory distress of unknown cause is unlikely to yield a diagnosis (whereas tests such as chest X-ray and lung ultrasound are far more likely to help).
- ABG/VBG occasionally can reveal the presence of hypercapnic encephalopathy in a somnolent patient with no obvious respiratory compromise. Such patients generally have a history of chronic hypercapnia (e.g. severe COPD or obesity hypoventilation syndrome).
- ABG/VBG can be helpful to monitor ventilation, especially among patients who are intubated or on BiPAP/HFNC. However, this is only one piece of information which should be carefully integrated with the overall clinical picture (e.g. the patient's overall appearance is generally more important than blood gas values).
VBG vs. ABG?
- For most patients oxygenation can be measured with pulse oximetry. Therefore, the only information we get from VBG/ABG is the pH and pCO2. If we already know the patient's bicarbonate from serum chemistries, then VBG/ABG provides only one independent piece of information (because the pCO2 will determine the pH based on the Henderson-Hasselbach equation).
- VBG values are extremely close to ABG values as long as the oxygen saturation from the venous blood gas isn't extremely low (VBG oxygen saturation >75%).🌊
- Most patients have a peripheral vein cannula that allows blood removal. A small amount of blood can be removed, allowing for painless and accurate monitoring of blood gas parameters. If venous blood is obtained without a tourniquet and analyzed immediately, it will generally have a saturation >75%, yielding accurate information.
- If VBG oxygen saturation is very low (<50-60%), then pH and pCO2 values will be off slightly. However, they won't be far off and the direction of deviation is predictable:
- VBG pCO2 > ABG pCO2
- VBG pH < ABG pH
- Clinical management should never hinge on tiny differences in ABG/VBG parameters. Therefore, it's generally fine to use VBG parameters. Remember: the decision to intubate is based on clinical judgement, not numbers.
end tidal CO2 (etCO2) 📖
- For intubated patients, etCO2 can be used to estimate and trend the patient's arterial pCO2.
- etCO2 will always underestimate blood pCO2, because gas in the trachea dilutes CO2 as it travels from the alveoli to the ventilator.
- If the etCO2 is >45 mm, then the patient is definitely hypercapneic.
- The gap between etCO2 and pCO2 depends on how healthy the lungs are:
- In healthy lungs, this gap is usually <15 mm.
- In patients with lung disease (e.g. COPD, pneumonia, ARDS, PE, pulmonary contusion) the gap will widen.
- For most patients, after intubation the respiratory rate should usually be adjusted to achieve an etCO2 of ~30 mm. This should put the pCO2 in a safe range (~35-65 mm).
- One exception would be in patients with severe metabolic acidosis, in whom the respiratory rate should initially be maximized in efforts to provide a compensatory respiratory alkalosis.
- Minute ventilation is the volume of gas moving in/out of the lungs every minute. A normal minute ventilation is ~6-7 liters/min.
- Patients with ineffective ventilation (ventilation/perfusion mismatch, for example, due to COPD or ARDS) will need a higher minute ventilation to achieve a normal pCO2 level (e.g. 10-14 liters/minute).
- Minute ventilation is displayed on the screen of the ventilator of BiPAP machine. For patients on BiPAP, minute ventilation is accurate only in the absence of an air leak around the mask.
- Paying attention to minute ventilation can be extremely helpful, especially for patients on BiPAP. For example:
- A COPD patient with minute ventilation of >9 liters/min: this patient is probably ventilating OK.
- A COPD patient with minute ventilation <6 liters/min: this patient is probably hypercapneic.
Approach to fever in the ICU
common causes 📖
- Infection: (~50% of cases)
- C. difficile, Acalculous cholecystitis.
- Line infection.
- Surgical site infection.
- Non-infectious: (~50% of cases)
- Procedure-related (hemodialysis, bronchoscopy, 1-3 days post-surgery).
- Drug fever.
- Febrile transfusion reaction.
- Sterile inflammation (pancreatitis, aspiration pneumonitis, ARDS).
- Pulmonary embolism.
- Alcohol withdrawal.
- Central fever (intracranial hemorrhage).
- Physical examination as above.
- Chest X-ray if intubated or symptoms of pneumonia.
- Blood cultures:
- At least two sets of cultures from different venipuncture sites, with at least one peripheral culture.
- Any line in place >48 hours should be cultured.
- C. difficile testing, if diarrhea.
- Further testing per clinical judgement (e.g. abdominal CT scan, CT angio for PE).
test to usually avoid
- Urinalysis & culture from foley catheter: In the absence of urinary obstruction or recent urinary tract manipulation, cystitis is rarely the cause of new-onset fever. Routinely culturing urine in all febrile ICU patients will tend to cause false-positive diagnoses of urinary tract infection.📖
- Tracheal aspirate cultures: These will generally be positive due to colonization in anyone with COPD, cystic fibrosis, or prolonged intubation. Obtain sputum cultures only if there is a genuine clinical suspicion for pneumonia (e.g. based on increased sputum production, hypoxemia, or chest X-ray infiltrates).📖
avoid antipyretics (acetaminophen)
- It's generally best to avoid antipyretics, as these will obscure the true fever curve.
- Indications for antipyretics:
- Neurologic injury (e.g., stroke, anoxic brain injury).
- Severe fever (e.g. >40C/104F).
- Fever appears to cause clinical deterioration (fever can cause some patients to become delirious or tachycardic).
avoid empiric antibiotics
- Fever isn't an indication for antibiotics.
- Antibiotics may be indicated in specific situations:
- Neutropenic fever (absolute neutrophil count <500 -or- <1,000 and falling).
- Septic shock.
- High index of suspicion for a specific infection (e.g. C. difficile) – empiric antibiotics directed at this source may be started while awaiting test results.
Questions & discussion
To keep this page small and fast, questions & discussion about this post can be found on another page here.
Guide to emoji hyperlinks
- = Link to online calculator.
- = Link to Medscape monograph about a drug.
- = Link to IBCC section about a drug.
- = Link to IBCC section covering that topic.
- = Link to FOAMed site with related information.
- = Link to supplemental media.
- 01976875 Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group. Lancet. 1990 Oct 6;336(8719):827-30 [PubMed]
- 08006281 Holdright D, Patel D, Cunningham D, Thomas R, Hubbard W, Hendry G, Sutton G, Fox K. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol. 1994 Jul;24(1):39-45. doi: 10.1016/0735-1097(94)90539-8 [PubMed]
- 08284001 Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJ, Roy P, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994 Feb 10;330(6):377-81. doi: 10.1056/NEJM199402103300601 [PubMed]
- 08596317 Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet. 1996 Mar 2;347(9001):561-8 [PubMed]
- 09377880 Sieger B, Berman SJ, Geckler RW, Farkas SA. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group. Crit Care Med. 1997 Oct;25(10):1663-70. doi: 10.1097/00003246-199710000-00015 [PubMed]
- 09507131 Jevtovic-Todorovic V, Wozniak DF, Powell S, Nardi A, Olney JW. Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects. Brain Res. 1998 Jan 19;781(1-2):202-11. doi: 10.1016/s0006-8993(97)01247-x [PubMed]
- 10499950 Green SM, Clark R, Hostetler MA, Cohen M, Carlson D, Rothrock SG. Inadvertent ketamine overdose in children: clinical manifestations and outcome. Ann Emerg Med. 1999 Oct;34(4 Pt 1):492-7. doi: 10.1016/s0196-0644(99)80051-1 [PubMed]
- 10773503 Handa F, Tanaka M, Nishikawa T, Toyooka H. Effects of oral clonidine premedication on side effects of intravenous ketamine anesthesia: a randomized, double-blind, placebo-controlled study. J Clin Anesth. 2000 Feb;12(1):19-24. doi: 10.1016/s0952-8180(99)00131-2 [PubMed]
- 11573854 Yuan RY, Kao CR, Sheu JJ, Chen CH, Ho CS. Delirium following a switch from cimetidine to famotidine. Ann Pharmacother. 2001 Sep;35(9):1045-8. doi: 10.1345/aph.10182 [PubMed]
- 11793615 Cohen JS. Peripheral neuropathy associated with fluoroquinolones. Ann Pharmacother. 2001 Dec;35(12):1540-7. doi: 10.1345/aph.1Z429 [PubMed]
- 11979336 Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002 May;39(5):930-6. doi: 10.1053/ajkd.2002.32766 [PubMed]
- 12576944 Nguyen BV, Bota DP, Mélot C, Vincent JL. Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med. 2003 Feb;31(2):406-10. doi: 10.1097/01.CCM.0000048623.00778.3F [PubMed]
- 12933413 Guillou N, Tanguy M, Seguin P, Branger B, Campion JP, Mallédant Y. The effects of small-dose ketamine on morphine consumption in surgical intensive care unit patients after major abdominal surgery. Anesth Analg. 2003 Sep;97(3):843-847. doi: 10.1213/01.ANE.0000075837.67275.36 [PubMed]
- 14581110 Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003 Nov;106(1-2):49-57. doi: 10.1016/s0304-3959(03)00276-8 [PubMed]
- 15845718 O'Malley CMN, Frumento RJ, Hardy MA, Benvenisty AI, Brentjens TE, Mercer JS, Bennett-Guerrero E. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg. 2005 May;100(5):1518-1524. doi: 10.1213/01.ANE.0000150939.28904.81 [PubMed]
- 15983467 Joly V, Richebe P, Guignard B, Fletcher D, Maurette P, Sessler DI, Chauvin M. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology. 2005 Jul;103(1):147-55. doi: 10.1097/00000542-200507000-00022 [PubMed]
- 15996033 Wang WH, Huang JQ, Zheng GF, Xia HH, Wong WM, Lam SK, Wong BC. Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis. World J Gastroenterol. 2005 Jul 14;11(26):4067-77. doi: 10.3748/wjg.v11.i26.4067 [PubMed]
- 16206099 Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005 Nov 1;41(9):1254-60. doi: 10.1086/496986 [PubMed]
- 16477553 Charbonneau P, Parienti JJ, Thibon P, Ramakers M, Daubin C, du Cheyron D, Lebouvier G, Le Coutour X, Leclercq R; French Fluoroquinolone Free (3F) Study Group. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin Infect Dis. 2006 Mar 15;42(6):778-84. doi: 10.1086/500319 [PubMed]
- 16854557 Visser E, Schug SA. The role of ketamine in pain management. Biomed Pharmacother. 2006 Aug;60(7):341-8. doi: 10.1016/j.biopha.2006.06.021 [PubMed]
- 17884829 Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother. 2007 Nov;60(5):1124-30. doi: 10.1093/jac/dkm356 [PubMed]
- 11794168 van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67. doi: 10.1056/NEJMoa011300 [PubMed]
- 18091545 Heyland DK, Dodek P, Muscedere J, Day A, Cook D; Canadian Critical Care Trials Group. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med. 2008 Mar;36(3):737-44. doi: 10.1097/01.CCM.0B013E31816203D6 [PubMed]
- 18184958 Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008 Jan 10;358(2):125-39. doi: 10.1056/NEJMoa070716 [PubMed]
- 18569935 Khajavi MR, Etezadi F, Moharari RS, Imani F, Meysamie AP, Khashayar P, Najafi A. Effects of normal saline vs. lactated ringer's during renal transplantation. Ren Fail. 2008;30(5):535-9. doi: 10.1080/08860220802064770 [PubMed]
- 18628220 Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008 Jul;134(1):172-8. doi: 10.1378/chest.07-2331 [PubMed]
- 19095506 Sollazzi L, Modesti C, Vitale F, Sacco T, Ciocchetti P, Idra AS, Tacchino RM, Perilli V. Preinductive use of clonidine and ketamine improves recovery and reduces postoperative pain after bariatric surgery. Surg Obes Relat Dis. 2009 Jan-Feb;5(1):67-71. doi: 10.1016/j.soard.2008.09.018 [PubMed]
- 19272635 Rondina MT, Wheeler M, Rodgers GM, Draper L, Pendleton RC. Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients. Thromb Res. 2010 Mar;125(3):220-3. doi: 10.1016/j.thromres.2009.02.003 [PubMed]
- 19318384 NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625 [PubMed]
- 19773646 Napolitano LM, Kurek S, Luchette FA, et al.; American College of Critical Care Medicine of the Society of Critical Care Medicine; Eastern Association for the Surgery of Trauma Practice Management Workgroup. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009 Dec;37(12):3124-57. doi: 10.1097/CCM.0b013e3181b39f1b [PubMed]
- 19783371 Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain. 2009 Dec 15;147(1-3):107-15. doi: 10.1016/j.pain.2009.08.015 [PubMed]
- 19861528 Poulard F, Dimet J, Martin-Lefevre L, Bontemps F, Fiancette M, Clementi E, Lebert C, Renard B, Reignier J. Impact of not measuring residual gastric volume in mechanically ventilated patients receiving early enteral feeding: a prospective before-after study. JPEN J Parenter Enteral Nutr. 2010 Mar-Apr;34(2):125-30. doi: 10.1177/0148607109344745 [PubMed]
- 19915454 Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, Robbins T, Garpestad E. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010 Feb;38(2):419-27. doi: 10.1097/CCM.0b013e3181b9e302 [PubMed]
- 19966732 Baid H. A critical review of auscultating bowel sounds. Br J Nurs. 2009 Oct 8-21;18(18):1125-9. doi: 10.12968/bjon.2009.18.18.44555 [PubMed]
- 20189753 Memis D, Inal MT, Kavalci G, Sezer A, Sut N. Intravenous paracetamol reduced the use of opioids, extubation time, and opioid-related adverse effects after major surgery in intensive care unit. J Crit Care. 2010 Sep;25(3):458-62. doi: 10.1016/j.jcrc.2009.12.012 [PubMed]
- 20648205 Nama S, Meenan DR, Fritz WT. The use of sub-anesthetic intravenous ketamine and adjuvant dexmedetomidine when treating acute pain from CRPS. Pain Physician. 2010 Jul-Aug;13(4):365-8 [PubMed]
- 20845391 Al-Aama T, Brymer C, Gutmanis I, Woolmore-Goodwin SM, Esbaugh J, Dasgupta M. Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatr Psychiatry. 2011 Jul;26(7):687-94. doi: 10.1002/gps.2582 [PubMed]
- 21144988 Rotschafer JC, Ullman MA, Sullivan CJ. Optimal use of fluoroquinolones in the intensive care unit setting. Crit Care Clin. 2011 Jan;27(1):95-106. doi: 10.1016/j.ccc.2010.11.005 [PubMed]
- 21663600 Burri E, Potocki M, Drexler B, Schuetz P, Mebazaa A, Ahlfeld U, Balmelli C, Heinisch C, Noveanu M, Breidthardt T, Schaub N, Reichlin T, Mueller C. Value of arterial blood gas analysis in patients with acute dyspnea: an observational study. Crit Care. 2011;15(3):R145. doi: 10.1186/cc10268 [PubMed]
- 21742459 Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: a literature review. J Emerg Med. 2012 May;42(5):612-20. doi: 10.1016/j.jemermed.2011.05.035 [PubMed]
- 21996380 Asensio A, Alvarez-Espejo T, Fernandez-Crehuet J, Ramos A, Vaque-Rafart J, Bishopberger C, Hernandez Navarrete M, Calbo-Torrecillas F, Campayo J, Canton R; Estudio de Prevalencia de las Infecciones Nosocomiales en Espana (EPINE) Working Group. Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010. Euro Surveill. 2011 Oct 6;16(40):19983. doi: 10.2807/ese.16.40.19983-en [PubMed]
- 22237237 Modi MP, Vora KS, Parikh GP, Shah VR. A comparative study of impact of infusion of Ringer's Lactate solution versus normal saline on acid-base balance and serum electrolytes during live related renal transplantation. Saudi J Kidney Dis Transpl. 2012 Jan;23(1):135-7 [PubMed]
- 22420584 Wanzuita R, Poli-de-Figueiredo LF, Pfuetzenreiter F, Cavalcanti AB, Westphal GA. Replacement of fentanyl infusion by enteral methadone decreases the weaning time from mechanical ventilation: a randomized controlled trial. Crit Care. 2012 Dec 12;16(2):R49. doi: 10.1186/cc11250 [PubMed]
- 22477787 Tobias JD. Dexmedetomidine: Are There Going to be Issues with Prolonged Administration? J Pediatr Pharmacol Ther. 2010 Jan;15(1):4-9 [PubMed]
- 22580944 Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012 Jul;256(1):18-24. doi: 10.1097/SLA.0b013e318256be72 [PubMed]
- 22763634 Tamma PD, Cosgrove SE, Maragakis LL. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev. 2012 Jul;25(3):450-70. doi: 10.1128/CMR.05041-11 [PubMed]
- 22921930 Vardakas KZ, Konstantelias AA, Loizidis G, Rafailidis PI, Falagas ME. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis. Int J Infect Dis. 2012 Nov;16(11):e768-73. doi: 10.1016/j.ijid.2012.07.010 [PubMed]
- 22929300 Van der Linden T, Souweine B, Dupic L, Soufir L, Meyer P. Management of thrombocytopenia in the ICU (pregnancy excluded). Ann Intensive Care. 2012 Aug 28;2(1):42. doi: 10.1186/2110-5820-2-42 [PubMed]
- 22949902 Fujii S, Tanimukai H, Kashiwagi Y. Comparison and analysis of delirium induced by histamine h(2) receptor antagonists and proton pump inhibitors in cancer patients. Case Rep Oncol. 2012 May;5(2):409-12. doi: 10.1159/000341873 [PubMed]
- 23073953 Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012 Oct 17;308(15):1566-72. doi: 10.1001/jama.2012.13356 [PubMed]
- 23269131 Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, Coursin DB, Herr DL, Tung A, Robinson BR, Fontaine DK, Ramsay MA, Riker RR, Sessler CN, Pun B, Skrobik Y, Jaeschke R; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013 Jan;41(1):263-306. doi: 10.1097/CCM.0b013e3182783b72 [PubMed]
- 23281973 Villanueva C, Colomo A, Bosch A, Concepción M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, Guarner-Argente C, Santaló M, Muñiz E, Guarner C. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013 Jan 3;368(1):11-21. doi: 10.1056/NEJMoa1211801 [PubMed]
- 23318494 Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med. 2013 Mar;41(3):693-705. doi: 10.1097/CCM.0b013e3182758734 [PubMed]
- 23321763 Reignier J, Mercier E, Le Gouge A, Boulain T, Desachy A, Bellec F, Clavel M, Frat JP, Plantefeve G, Quenot JP, Lascarrou JB; Clinical Research in Intensive Care and Sepsis (CRICS) Group. Effect of not monitoring residual gastric volume on risk of ventilator-associated pneumonia in adults receiving mechanical ventilation and early enteral feeding: a randomized controlled trial. JAMA. 2013 Jan 16;309(3):249-56. doi: 10.1001/jama.2012.196377 [PubMed]
- 23410791 Vardakas KZ, Tansarli GS, Bliziotis IA, Falagas ME. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis. Int J Antimicrob Agents. 2013 Apr;41(4):301-10. doi: 10.1016/j.ijantimicag.2012.12.006 [PubMed]
- 23470218 Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care. 2013 Mar 6;17(2):305. doi: 10.1186/cc12514 [PubMed]
- 23506859 Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013 Sep;11(9):1064-74. doi: 10.1016/j.cgh.2013.02.026 [PubMed]
- 23509136 Young JW, Juurlink DN. Tramadol. CMAJ. 2013 May 14;185(8):E352. doi: 10.1503/cmaj.121592 [PubMed]
- 23709472 Qaseem A, Chou R, Humphrey LL, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Inpatient glycemic control: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Am J Med Qual. 2014 Mar-Apr;29(2):95-8. doi: 10.1177/1062860613489339 [PubMed]
- 23711600 Nitta R, Goyagi T, Nishikawa T. Combination of oral clonidine and intravenous low-dose ketamine reduces the consumption of postoperative patient-controlled analgesia morphine after spine surgery. Acta Anaesthesiol Taiwan. 2013 Mar;51(1):14-7. doi: 10.1016/j.aat.2013.03.003 [PubMed]
- 23774337 Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013 Jul;41(7):1774-81. doi: 10.1097/CCM.0b013e31828a25fd [PubMed]
- 23782973 Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2013 Sep;41(9):2088-98. doi: 10.1097/CCM.0b013e31828cf104 [PubMed]
- 24136071 Wang TF, Milligan PE, Wong CA, Deal EN, Thoelke MS, Gage BF. Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost. 2014 Jan;111(1):88-93. doi: 10.1160/TH13-01-0042 [PubMed]
- 24139926 Hu Y, Li L, Li W, Xu H, He P, Yan X, Dai H. Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies. Int J Antimicrob Agents. 2013 Dec;42(6):492-6. doi: 10.1016/j.ijantimicag.2013.09.002 [PubMed]
- 24395715 Paul M, Lador A, Grozinsky-Glasberg S, Leibovici L. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev. 2014 Jan 7;2014(1):CD003344. doi: 10.1002/14651858.CD003344.pub3 [PubMed]
- 24554232 Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, Nakamura H; DELIRIA-J Group. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry. 2014 Apr;71(4):397-403. doi: 10.1001/jamapsychiatry.2013.3320 [PubMed]
- 25003980 Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, Montini L, De Gaetano A, Navalesi P, Antonelli M. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med. 2014 Aug 1;190(3):282-8. doi: 10.1164/rccm.201402-0364OC [PubMed]
- 25029573 Plummer MP, Blaser AR, Deane AM. Stress ulceration: prevalence, pathology and association with adverse outcomes. Crit Care. 2014 Mar 18;18(2):213. doi: 10.1186/cc13780 [PubMed]
- 25423877 Douros A, Grabowski K, Stahlmann R. Safety issues and drug-drug interactions with commonly used quinolones. Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):25-39. doi: 10.1517/17425255.2014.970166 [PubMed]
- 25477978 Imani F, Motavaf M, Safari S, Alavian SM. The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. Hepat Mon. 2014 Oct 11;14(10):e23539. doi: 10.5812/hepatmon.23539 [PubMed]
- 25530168 Jouguelet-Lacoste J, La Colla L, Schilling D, Chelly JE. The use of intravenous infusion or single dose of low-dose ketamine for postoperative analgesia: a review of the current literature. Pain Med. 2015 Feb;16(2):383-403. doi: 10.1111/pme.12619 [PubMed]
- 25700059 Paiva JA, Pereira JM. Fluoroquinolones: another line in the long list of their collateral damage record. Crit Care Med. 2015 Mar;43(3):708-10. doi: 10.1097/CCM.0000000000000802 [PubMed]
- 25809176 Gagnon DJ, Riker RR, Glisic EK, Kelner A, Perrey HM, Fraser GL. Transition from dexmedetomidine to enteral clonidine for ICU sedation: an observational pilot study. Pharmacotherapy. 2015 Mar;35(3):251-9. doi: 10.1002/phar.1559 [PubMed]
- 25969139 Mistraletti G, Umbrello M, Sabbatini G, Miori S, Taverna M, Cerri B, Mantovani ES, Formenti P, Spanu P, D'Agostino A, Salini S, Morabito A, Fraschini F, Reiter RJ, Iapichino G. Melatonin reduces the need for sedation in ICU patients: a randomized controlled trial. Minerva Anestesiol. 2015 Dec;81(12):1298-310 [PubMed]
- 25981908 Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Béduneau G, Delétage-Métreau C, Richard JC, Brochard L, Robert R; FLORALI Study Group; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015 Jun 4;372(23):2185-96. doi: 10.1056/NEJMoa1503326 [PubMed]
- 26025196 Moitra VK, Patel MK, Darrah D, Moitra A, Wunsch H. Low-Dose Ketamine in Chronic Critical Illness. J Intensive Care Med. 2016 Mar;31(3):216-20. doi: 10.1177/0885066615587868 [PubMed]
- 26073560 Acheampong A, Vincent JL. A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care. 2015 Jun 15;19(1):251. doi: 10.1186/s13054-015-0970-1 [PubMed]
- 26095487 Lyons PJ, Rivosecchi RM, Nery JP, Kane-Gill SL. Fentanyl-induced hyperalgesia in acute pain management. J Pain Palliat Care Pharmacother. 2015 Jun;29(2):153-60. doi: 10.3109/15360288.2015.1035835 [PubMed]
- 26330729 Chowdhry V, Padhi M, Mohanty BB, Mohapatra S. Fluoroquinolones: An under-recognized cause for delirium. J Anaesthesiol Clin Pharmacol. 2015 Jul-Sep;31(3):410-1. doi: 10.4103/0970-9185.161686 [PubMed]
- 26346209 Reardon DP, Anger KE, Szumita PM. Pathophysiology, assessment, and management of pain in critically ill adults. Am J Health Syst Pharm. 2015 Sep 15;72(18):1531-43. doi: 10.2146/ajhp140541 [PubMed]
- 26741578 Litton E, Carnegie V, Elliott R, Webb SA. The Efficacy of Earplugs as a Sleep Hygiene Strategy for Reducing Delirium in the ICU: A Systematic Review and Meta-Analysis. Crit Care Med. 2016 May;44(5):992-9. doi: 10.1097/CCM.0000000000001557 [PubMed]
- 26768425 Bashir MU, Tawil A, Mani VR, Farooq U, A DeVita M. Hidden Obligatory Fluid Intake in Critical Care Patients. J Intensive Care Med. 2017 Mar;32(3):223-227. doi: 10.1177/0885066615625181 [PubMed]
- 26773077 McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA, Gervasio JM, Sacks GS, Roberts PR, Compher C; Society of Critical Care Medicine; American Society for Parenteral and Enteral Nutrition. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016 Feb;40(2):159-211. doi: 10.1177/0148607115621863 [PubMed]
- 26836730 Faisy C, Meziani F, Planquette B, Clavel M, Gacouin A, Bornstain C, Schneider F, Duguet A, Gibot S, Lerolle N, Ricard JD, Sanchez O, Djibre M, Ricome JL, Rabbat A, Heming N, Urien S, Esvan M, Katsahian S; DIABOLO Investigators. Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial. JAMA. 2016 Feb 2;315(5):480-8. doi: 10.1001/jama.2016.0019 [PubMed]
- 26836894 Aberegg SK. Ionized Calcium in the ICU: Should It Be Measured and Corrected? Chest. 2016 Mar;149(3):846-55. doi: 10.1016/j.chest.2015.12.001 [PubMed]
- 26919405 Lenze EJ, Farber NB, Kharasch E, Schweiger J, Yingling M, Olney J, Newcomer JW. Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial. World J Biol Psychiatry. 2016 Apr;17(3):230-8. doi: 10.3109/15622975.2016.1142607 [PubMed]
- 26948252 Bihari S, Holt AW, Prakash S, Bersten AD. Addition of indapamide to frusemide increases natriuresis and creatinine clearance, but not diuresis, in fluid overloaded ICU patients. J Crit Care. 2016 Jun;33:200-6. doi: 10.1016/j.jcrc.2016.01.017 [PubMed]
- 26975498 Hernández G, Vaquero C, González P, Subira C, Frutos-Vivar F, Rialp G, Laborda C, Colinas L, Cuena R, Fernández R. Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on Reintubation in Low-Risk Patients: A Randomized Clinical Trial. JAMA. 2016 Apr 5;315(13):1354-61. doi: 10.1001/jama.2016.2711 [PubMed]
- 26975647 Reade MC, Eastwood GM, Bellomo R, Bailey M, Bersten A, Cheung B, Davies A, Delaney A, Ghosh A, van Haren F, Harley N, Knight D, McGuiness S, Mulder J, O'Donoghue S, Simpson N, Young P; DahLIA Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial. JAMA. 2016 Apr 12;315(14):1460-8. doi: 10.1001/jama.2016.2707 [PubMed]
- 27315191 Kar P, Plummer MP, Bellomo R, Jenkins AJ, Januszewski AS, Chapman MJ, Jones KL, Horowitz M, Deane AM. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study. Crit Care Med. 2016 Sep;44(9):1695-703. doi: 10.1097/CCM.0000000000001815 [PubMed]
- 27656531 Trivedi S, Kumar R, Tripathi AK, Mehta RK. A Comparative Study of Dexmedetomidine and Midazolam in Reducing Delirium Caused by Ketamine. J Clin Diagn Res. 2016 Aug;10(8):UC01-4. doi: 10.7860/JCDR/2016/18397.8225 [PubMed]
- 27714833 Turco NJ, Samuel S, Choi HA. High-Dose Venous Thromboembolism Prophylaxis for Obese Patients. Pharmacotherapy. 2016 Nov;36(11):e198-e199. doi: 10.1002/phar.1842 [PubMed]
- 28130687 Marik PE, Linde-Zwirble WT, Bittner EA, Sahatjian J, Hansell D. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med. 2017 May;43(5):625-632. doi: 10.1007/s00134-016-4675-y [PubMed]
- 28284299 Napolitano LM. Anemia and Red Blood Cell Transfusion: Advances in Critical Care. Crit Care Clin. 2017 Apr;33(2):345-364. doi: 10.1016/j.ccc.2016.12.011 [PubMed]
- 28468568 Buchheit JL, Yeh DD, Eikermann M, Lin H. Impact of Low-Dose Ketamine on the Usage of Continuous Opioid Infusion for the Treatment of Pain in Adult Mechanically Ventilated Patients in Surgical Intensive Care Units. J Intensive Care Med. 2019 Aug;34(8):646-651. doi: 10.1177/0885066617706907 [PubMed]
- 28979516 Carroll I, Mount T, Atkinson D. Myocardial infarction in intensive care units: A systematic review of diagnosis and treatment. J Intensive Care Soc. 2016 Nov;17(4):314-325. doi: 10.1177/1751143716656642 [PubMed]
- 29110139 Pignon B, Tezenas du Montcel C, Carton L, Pelissolo A. The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders. Curr Psychiatry Rep. 2017 Nov 7;19(12):103. doi: 10.1007/s11920-017-0847-x [PubMed]
- 29121282 Weinberg L, Harris L, Bellomo R, Ierino FL, Story D, Eastwood G, Collins M, Churilov L, Mount PF. Effects of intraoperative and early postoperative normal saline or Plasma-Lyte 148® on hyperkalaemia in deceased donor renal transplantation: a double-blind randomized trial. Br J Anaesth. 2017 Oct 1;119(4):606-615. doi: 10.1093/bja/aex163 [PubMed]
- 29409760 Crockett SD, Wani S, Gardner TB, Falck-Ytter Y, Barkun AN; American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis. Gastroenterology. 2018 Mar;154(4):1096-1101. doi: 10.1053/j.gastro.2018.01.032 [PubMed]
- 29485925 Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, Stollings JL, Kumar AB, Hughes CG, Hernandez A, Guillamondegui OD, May AK, Weavind L, Casey JD, Siew ED, Shaw AD, Bernard GR, Rice TW; SMART Investigators and the Pragmatic Critical Care Research Group. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med. 2018 Mar 1;378(9):829-839. doi: 10.1056/NEJMoa1711584 [PubMed]
- 29485926 Self WH, Semler MW, Wanderer JP, Wang L, Byrne DW, Collins SP, Slovis CM, Lindsell CJ, Ehrenfeld JM, Siew ED, Shaw AD, Bernard GR, Rice TW; SALT-ED Investigators. Balanced Crystalloids versus Saline in Noncritically Ill Adults. N Engl J Med. 2018 Mar 1;378(9):819-828. doi: 10.1056/NEJMoa1711586 [PubMed]
- 29498534 Skrobik Y, Duprey MS, Hill NS, Devlin JW. Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial. Am J Respir Crit Care Med. 2018 May 1;197(9):1147-1156. doi: 10.1164/rccm.201710-1995OC [PubMed]
- 29595562 Nishikimi M, Numaguchi A, Takahashi K, Miyagawa Y, Matsui K, Higashi M, Makishi G, Matsui S, Matsuda N. Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial. Crit Care Med. 2018 Jul;46(7):1099-1105. doi: 10.1097/CCM.0000000000003132 [PubMed]
- 29870458 Cohen SP, Bhatia A, Buvanendran A, Schwenk ES, Wasan AD, Hurley RW, Viscusi ER, Narouze S, Davis FN, Ritchie EC, Lubenow TR, Hooten WM. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018 Jul;43(5):521-546. doi: 10.1097/AAP.0000000000000808 [PubMed]
- 30346225 TARGET Investigators, for the ANZICS Clinical Trials Group, Chapman M, Peake SL, Bellomo R, Davies A, Deane A, Horowitz M, Hurford S, Lange K, Little L, Mackle D, O’Connor S, Presneill J, Ridley E, Williams P, Young P. Energy-Dense versus Routine Enteral Nutrition in the Critically Ill. N Engl J Med. 2018 Nov 8;379(19):1823-1834. doi: 10.1056/NEJMoa1811687 [PubMed]
- 30354950 Krag M, Marker S, Perner A, et al.; SUP-ICU trial group. Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU. N Engl J Med. 2018 Dec 6;379(23):2199-2208. doi: 10.1056/NEJMoa1714919 [PubMed]
- 30355567 Siemieniuk RAC, Chu DK, Kim LH, Güell-Rous MR, Alhazzani W, Soccal PM, Karanicolas PJ, Farhoumand PD, Siemieniuk JLK, Satia I, Irusen EM, Refaat MM, Mikita JS, Smith M, Cohen DN, Vandvik PO, Agoritsas T, Lytvyn L, Guyatt GH. Oxygen therapy for acutely ill medical patients: a clinical practice guideline. BMJ. 2018 Oct 24;363:k4169. doi: 10.1136/bmj.k4169 [PubMed]
- 30571511 Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018 Nov 13;138(20):e618-e651. doi: 10.1161/CIR.0000000000000617 [PubMed]